SCHEMBL6949830

SCHEMBL6949830

CCCC1=NN(c2ccncc2)C(=O)C1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHMT2 P34897 1/20 0.60
GAA P10253 4/20 0.45
ALDH1A1 P00352 4/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MEN1 O00255 6/20 0.43
KMT2A Q03164 6/20 0.43
MAPT P10636 5/20 0.42
KDM4E B2RXH2 4/20 0.42
RECQL P46063 1/20 0.42
TDP1 Q9NUW8 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP1A2 P05177 1/20 0.41
CHRM2 P08172 1/20 0.41
CYP3A4 P08684 1/20 0.41
CHRM1 P11229 1/20 0.41
TSHR P16473 1/20 0.41
PTGS1 P23219 1/20 0.41
DRD3 P35462 1/20 0.41
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4664734 0.86 SHMT2 (0.82) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL5976250 0.86 SHMT2 (0.62) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL5975717 0.83 SHMT2 (0.59) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL5976498 0.83 SHMT2 (0.59) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL5975777 0.83 KMT2A (0.60) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL8427522 0.82 GAA (0.46) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL6953514 0.82 SHMT2 (0.58) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL5976511 0.82 SHMT2 (0.55) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL14559421 0.82 SHMT2 (0.57) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL1682581 0.81 KMT2A (0.66) SHMT2GAAALDH1A1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed